Understanding proper storage is as vital as the initial reconstitution
TLDR: "Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to obesity." Key findings: After stopping liraglutide, patients regained ~2.2 kg After stopping semaglutide/tirzepatide, patients regained ~9.7 kg Weight regain was proportional to initial weight loss Lifestyle changes alone DID NOT prevent regain Implication: GLP-1 receptor agonists are not a short-term solution
Sobo provides customized peptide therapy protocols, including CJC-1295 and Ipamorelin, at his medical practice in Stamford, CT
If this sparks interest, please contact your Affinity Patient Care Coordinator today
I am hardly eatng during the day and struggle to finish dinner
These appointments provide an opportunity to discuss all medications you are taking, including over-the-counter products and supplements, ensuring they remain appropriate and safe in combination